FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

28,490 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 9200 - 9400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
healthdata.be.r4.cbbR4AdministrationAgreementStopTypeAdministrationAgreementStopTypedraftsct
healthdata.be.r4.cbbR4AdministrationDeviceAdministrationDevicedraftsct tho
ee.hl7.fhir.base.r5R5ee-administrative-genderAdministrative Genderdraft2023-08eehl7fhir
ee.fhir.terminologyR5administrative-genderAdministrative Genderactive2025-06eehl7fhir
us.cdc.phinvadsR42.16.840.1.113883.1.11.1Administrative Gender (HL7 V3)active2019-01ustho
ForgePatientChart.0830R4telus-administrative-genderTELUS ValueSet - Administrative Genderdraft2020-11hl7fhir
fhir.kisumuhieR4gender-vsGenderdraft2025-06ushl7
fhir.kenyaPSIGR4administrative-gender-vsAdministrative Genderactive2025-07ushl7fhir
IdHIE.0vR4value-set-administrative-gender-id-coreValueSetAdministrativeGender (ID Core)active2023-06fhir
MyHIE.v4-testR4value-set-administrative-gender-my-coreValueSetAdministrativeGender (MY Core)active2023-01fhir
hl7.terminologyR5v3-xActEncounterReasonx_ActEncounterReasonactive2014-03uvhl7tho
dk.ehealth.sundhed.fhir.ig.coreR4administrative-statusAdministrative Statusactive2019-02dk
ans.fr.terminologiesR4jdv-hl7-v3-AdministrativeGender-cisisAdministrativeGenderactive2025-06frnationaltho
ca.ab.fhir.psabR4administrative-gender-abAdministrativeGender_ABdraft2024-06cahl7tho
nr.gp.leumitR4admission-typeAdmission Type codesdraft2025-03il
ca.infoway.io.ca-csdR4delivery-methodDelivery Methoddraftnationalsct
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.20.5.3--20200901000000AdresSoortCodelijstactivenlhl7tho
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.20.5.3--20171231000000AdresSoortCodelijstactivenlfhir
us.nlm.vsacR42.16.840.1.113762.1.4.1235.645Pneumococcal Vaccine HD_CN_ Allergyactive2025-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1235.638b.well Adult Tetanus Vaccine CNactive2025-04ushl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1235.648bwell COVID Vaccine CN_Metactive2025-04ushl7vsac
us.cdc.phinvadsR42.16.840.1.114222.4.11.7758Adverse Event Severity (TB)active2017-12ussct
hl7.eu.fhir.idea4rcR4adverse-event-type-eu-i4rcAdverse Event Typeactive2025-07euhl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.963Consequence of Adverse Eventactive2008-01ustho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7596Adverse Event Severity (Malaria)active2019-01ussct tho oid
MyHIE.v4-testR4value-set-adverseevent-event-my-coreValueSetAdverseEventEvent (MY Core)active2023-03sct
IdHIE.0vR4value-set-adverseevent-event-id-coreValueSetAdverseEventEvent (ID Core)draft2023-06sct
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.3.11.60.90.77.11.33--20140904000000Advies SEOactivenloid
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.3.11.60.90.77.11.257--20200406134358Advies_1e_trimester_SEOactivenloid
dk.kip.rkkp.fhir.ig.coreR4AfdelingDandemAfdelinger til DANDEMactive2023-03internal
hl7.eu.fhir.idea4rcR4vs-affectedOrgan-eu-i4rcAffected Organs (surgery)active2025-07euhl7fhir tho
hl7.eu.fhir.pcspR4vs-affectedOrgan-eu-pcspAffected Organs (surgery)draft2025-07euhl7internal sct
fhir.acme.affiliate-reportR4affiliate-type-vsAffiliate Type ValueSetdraft2025-05ushl7internal
hl7.fhir.us.registry-protocolsR4YesNoYes or Noactivecic2023-11ushl7sct tho
dk.kip.rkkp.fhir.ig.coreR4AflastendeProcedureAflastende procedure DCCGactive2022-09internal
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.13.1.2--20200901000000AfnameprocedureCodelijstactivenlhl7sct
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.12.5.3--20171231000000AfwijkendAdemhalingspatroonCodelijstactivenlfhir sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.3065Age Category (Animal)active2008-01ustho
d4l-data4life.covid-19.r4R4age-group-de.ValueSetAgegroupactive
us.cdc.phinvadsR42.16.840.1.114222.4.11.3259Age Group (Flu)active2009-01ussct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7905Age units (ARLN)active2019-01usucum
hl7.fhir.us.davinci-pdexR4ProvenanceAgentTypeProvenance Agent Typeinformativefm2025-06ushl7fhir tho
hl7.terminologyR5measure-aggregate-methodMeasure Aggregate Methodactivecqi2023-02uvhl7tho
ans.fr.nosR4JDV-J200-SousEnsembleAgregatStatutJuridique-RORJDV_J200-SousEnsembleAgregatStatutJuridique-RORactive2024-01frnational
de.medizininformatikinitiative.use-case.omiR4AiServiceStatusCodesVSAiServiceStatusCodesVSactive2024-12de
kvdigital.terminsynchronisation-tvsR4KBV-VS-116117-TERMINSERVICE-TVS-TSYNCH-Provenance-ActivityKBV_VS_116117_TERMINSERVICE_TVS_TERMINSYNCHRONISATION_Provenance_Activitydrafttho
dk.kip.rkkp.fhir.ig.coreR4AktivitetDKRRAktivitet (DKRR)active2022-09internal tho
dk.kip.rkkp.fhir.ig.coreR4GenoplivningGenoplivningactive2022-06internal
dk.kip.rkkp.fhir.ig.coreR4AktivitetSportDKRRAktivitet: Sport (DKRR)active2022-09internal
us.cdc.phinvadsR42.16.840.1.114222.4.11.8054Alanine aminotransferase (ALT) Result (Hepatitis)active2021-01ustho oid
hl7.eu.fhir.idea4rcR4alcoholUsageStatus-athena-eu-i4rcAlcohol Usage Status: Athenaactive2025-07euhl7
hl7.eu.fhir.idea4rcR4alcoholUsageStatus-snomed-eu-i4rcAlcohol Usage Status: SNOMED CTactive2025-07euhl7sct
ehealth4u.packageR4cyehr-vs-alcoholstatusCyprus EHR Value Set: Alcohol Statusactivesct
ehealth4u.packageR4cyehr-vs-alcoholtypesCyprus EHR Value Set: Alcohol Typesactivesct
us.cdc.phinvadsR42.16.840.1.114222.4.11.8019Alcohol Use Frequency (Anthrax)active2020-01ussct tho oid
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000AlcoholGebruikStatusCodelijstactivenlhl7sct tho
nictiz.fhir.nl.stu3.zib2015R32.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20150401000000AlcoholGebruikStatusCodelijstretirednlfhir sct
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20171231000000AlcoholGebruikStatusCodelijstactivenlfhir sct
healthdata.be.r4.cbbR4AlcoholUseStatusAlcoholUseStatusdraftsct
nictiz.fhir.nl.stu3.geboortezorgR32.16.840.1.113883.2.4.3.11.60.90.77.11.203--20141020155659Alcoholgebruikactivenloid
nz.central.ihub.igR4nzcr-flag-alert-category-vsNZ Central Region - Flag Alert Category Value Setactive2025-04nznational
nz.central.ihub.igR4nzcr-acombined-alert-category-vsNZ Central Region - Combined Alert Category Value Setactive2025-04nznational
nz.central.ihub.igR4nzcr-allergy-alert-category-vsNZ Central Region - Allergy Alert Category Value Setactive2025-04nznational
nz.central.ihub.igR4nzcr-flag-alert-code-vsNZ Central Region - Flag Alert Code Value Setactive2025-04nznationaltho
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000AlertNaamCodelijstactivenlhl7sct tho
nictiz.fhir.nl.stu3.zib2015R32.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20150401000000AlertNaamCodelijstretirednlfhir sct
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20171231000000AlertNaamCodelijstactivenlfhir sct
healthdata.be.r4.cbbR4AlertNameAlertNamedraftsct
healthdata.be.r4.cbbR4AlertTypeAlertTypedraftloinc
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20200901000000AlertTypeCodelijstactivenlhl7loinc
nictiz.fhir.nl.stu3.zib2015R32.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20150401000000AlertTypeCodelijstretirednlloinc
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.8.3.1--20171231000000AlertTypeCodelijstactivenlloinc
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.12.12.1--20200901000000AlertheidCodelijstactivenlhl7oid
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.12.12.1--20171231000000AlertheidCodelijstactivenloid
hl7.fhir.us.registry-protocolsR4StressTestCath PCI Selected Stress Testactivecic2023-11ushl7loinc
fhir.cdc.opioid-cds-r4R4barbiturate-medicationsBarbiturate Medicationsactive2025-02ushl7
fhir.cdc.opioid-cds-r4R4buprenorphine-and-methadone-medicationsBuprenorphine and Methadone medicationsactive2023-05ushl7
fhir.cdc.opioid-cds-r4R4buprenorphine-medicationsBuprenorphine Medicationsactive2025-02ushl7
hl7.terminologyR5cpt-usableAMA CPT Usable Codesactivevocab2023-08uvhl7cpt
fhir.dicomR4allAll DICOM Controlled Terminology Definitionsactive2025-04ushl7dcm
il.core.fhir.r4R4icd9-cm-diagnosesIcd9 Cm diagnosesactive2025-03ilnationalicd
hl7.v2plusR5data-typesv2DataTypestrial-useinm2025-07hl7
hl7.fhir.us.icsr-ae-reportingR4ISBTConvalescentPlasmaCodeVSISBT Convalescent Plasma Codesdraft2023-08ushl7
hl7.fhir.us.icsr-ae-reportingR4ISBTBloodProductCodeVSISBT Blood Product Codesdraft2023-08ushl7
hl7.fhir.us.registry-protocolsR4SEattleAnginaQsSeattle Angina Questionsactivecic2023-11ushl7loinc
fhir.tx.support.r4R4covid-19-obsCOVID-19 related Observation codesdraft2020-03ushl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1267.13Screening and Assessment Survey Codesactive2024-10ushl7loinc
hl7.org.nz.fhir.ig.formularyR4BNzmtCodesNZMT Codesactive2025-07nzhl7
fhir.cdc.opioid-cds-r4R4oxycodone-medicationsOxycodone Medicationsactive2025-02ushl7
il.core.fhir.r4R4icd9-cm-proceduresIcd9 Cm Proceduresactive2025-03ilnationalicd
us.cdc.phinvadsR42.16.840.1.114222.4.11.6053Lab Test Name (Reportable Conditions)active2017-01usloinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.6054Lab Test Result (Reportable Conditions)active2016-01ussct
us.nlm.vsacR42.16.840.1.113762.1.4.1190.58Diabetes Medicationsactive2022-03ushl7rx
fhir.tx.support.r4R4covid-19-condCOVID-19 related Condition codesdraft2020-03ushl7sct
hl7.fhir.us.registry-protocolsR4HemodialysisOrPeritonealDialysishemodialysis or peritoneal dialysisactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4CardiacArrestCardiac Arrestactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4CABGCoronary artery bypass graftingactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4CerebrovascularDiseaseCerebrovascular Diseaseactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4PeripheralArterialOcclusiveDiseasePeripheral Arterial Occlusive Diseaseactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4DiabetesMellitusDiabetes Mellitusactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4DyslipidemiaDyslipidemiaactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4HeartFailureHeart Failure codes from SNOMEDactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4HypertensionHypertensionactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4PercutaneousCoronaryInterventionPCIactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4PriorCABGPrior History of Coronary Artery Bypass Graftactivecic2023-11ushl7sct loinc
hl7.fhir.us.registry-protocolsR4HypothermiaInducedInduced Hypothermia Codesactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4OrganDonorSNOMED Valueset of Organ Donor codesactivecic2023-11ushl7sct
hl7.fhir.us.registry-protocolsR4AbnormalElectrocardiacAssessmentAbnormal Electrocardiac Assessmentactivecic2023-11ushl7sct
fhir.cdc.opioid-cds-r4R4benzodiazepine-medicationsBenzodiazepine medicationsactive2025-02ushl7
us.nlm.vsacR42.16.840.1.113762.1.4.1260.230All Cancer Directed therapiesactive2024-05ushl7rx
example.fhir.ph.coreR4educational-attainmentsEducational Attainmentsdraft2025-06
example.fhir.ph.coreR4citiesCitiesdraft2025-06internal
silfhirprofileigR5ICD11CodesAll ICD-11 codesactive2025-07internal
silfhirprofileigR5ICHICodesAll ICHI codesactive2025-07
il.core.fhir.r4R4immunization-body-siteImmunization Observation Body Site listactive2025-03ilnationalsct
hl7.terminologyR5v3-IndividualCaseSafetyReportTypeIndividualCaseSafetyReportTypeactive2014-03uvhl7tho
de.netzwerk-universitaetsmedizin.ebm-cpgR5cochrane-picoCochrane PICOdraft2022-09uvhl7
hl7.fhir.uv.sanerR4MeasureScoringMeasure Scoringactivepher2024-05uvhl7fhir
hl7.terminologyR5cpt-allAMA CPT All Codesactivevocab2023-08uvhl7cpt
hl7.terminologyR5cpt-baseAMA CPT Base Codesactivevocab2023-08uvhl7cpt
hl7.fhir.us.registry-protocolsR4FamilyPrematureCADFamily History of Premature CADactivecic2023-11ushl7sct loinc
hl7.fhir.uv.cqmR4iso-8601-derived-periodsISO-8601-Derived Periodsactivecqi2025-06uvhl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1196.158Multiple Myeloma Regimen Drugsactive2019-08ushl7rx
ee.hl7.fhir.base.r5R5ee-identity-systemIdentity Systemdraft2023-08eehl7internal
ee.fhir.terminologyR5identifier-domainIdentity Systemactive2025-06eehl7internal
de.netzwerk-universitaetsmedizin.ebm-cpgR5cochrane-pico-interventionCochrane PICO Interventiondraft2022-09uvhl7
hl7.eu.fhir.unicomR5language-bcp-vsLanguage (FHIR)draft2025-06euhl7fhir
medcom.fhir.dk.terminologyR4medcom-messaging-messageTypesMedComMessagingMessageTypesactive2023-10dkinternal
fhir.cdc.opioid-cds-r4R4naloxone-medicationsNaloxone medicationsactive2025-02ushl7
fhir.cdc.opioid-cds-r4R4cdc-malignant-cancer-conditionsCDC malignant cancer conditionsactive2023-05ushl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1196.226Opioids, Allactive2024-01ushl7rx
fhir.cdc.opioid-cds-r4R4opioid-analgesics-with-ambulatory-misuse-potentialOpioid analgesics with ambulatory misuse potentialactive2025-02ushl7
fhir.cdc.opioid-cds-r4R4extended-release-opioid-with-ambulatory-misuse-potentialExtended release opioid with ambulatory misuse potentialactive2025-02ushl7
de.netzwerk-universitaetsmedizin.ebm-cpgR5cochrane-pico-outcomeCochrane PICO Outcomedraft2022-09uvhl7
de.netzwerk-universitaetsmedizin.ebm-cpgR5cochrane-pico-populationCochrane PICO Populationdraft2022-09uvhl7
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1053Carbidopa Levodopa Combination (RXNORM)active2025-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2362Tuberculosis (Ethambutol) (RXNORM)active2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2363Tuberculosis (Isoniazid [INH]) (RXNORM)active2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2364Tuberculosis (Pyrazinamide [PZA]) (RXNORM)active2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2365Tuberculosis (Rifabutin) (RXNORM)active2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2366Tuberculosis (Rifampin) (RXNORM)active2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2367Tuberculosis (Rifapentine) (RXNORM)active2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.741Hepatitis B Immune Globulin (RXNORM)active2023-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.747Penicillin G [Benzathine] [Injectable] [Bicillin] (RXNORM)active2025-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.844Tuberculosis (Second Line Drugs for Treatment) (RXNORM)active2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.991Rifampin (RXNORM)active2024-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1594HIV Infection (ARV Nucleoside Reverse Transcriptase Inhibitors [NRTIs]) (RXNORM)active2023-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1595HIV Infection (ARV Non nucleoside Reverse Transcriptase Inhibitors [NNRTIs]) (RXNORM)active2023-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1597HIV Infection (ARV Combination Treatment for HIV) (RXNORM)active2023-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1598HIV Infection (ARV Protease Inhibitors [PIs]) (RXNORM)active2023-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1600HIV Infection (ARV Integrase Strand Transfer Inhibitors [INSTIs]) (RXNORM)active2023-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1634Sofosbuvir Velpatasvir Combination (RXNORM)active2023-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1912Penicillin G [Aqueous Crystalline] [Injectable] (RXNORM)active2023-01ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1913Penicillin G [Procaine] [Injectable] (RXNORM)active2025-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1078Opioid Overdose and Poisoning (Naloxone) (RxNorm)active2025-02ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1618Smallpox Vaccine (RXNORM)active2023-06ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2142Linezolid (RXNORM)active2023-01ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2143Tuberculosis (Pretomanid) (RXNORM)active2023-01ushl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1146.2144Tuberculosis (Bedaquiline) (RXNORM)active2023-01ushl7rx
example.fhir.ph.coreR4provincesProvincesdraft2025-06internal
hl7.terminologyR5v3-EntityClassMicroorganismEntityClassMicroorganismactive2014-03uvhl7tho
hl7.fhir.uv.extensionsR5questionnaire-derivationTypeQuestionnaire Derivation Type Valuesetdraftfhir2025-07uvhl7fhir
de.netzwerk-universitaetsmedizin.ebm-cpgR5vs-substances-snomedSubstances SNOMED CTdraft2022-09uvhl7sct
poc.bonsai.currentR4provenance-activity-typesHändelsetypactive2024-02
kbv.ita.vosR4KBV-VS-VoS-SectionTypeKBV_VS_VoS_SectionTypeactive2023-02
KBV.ITA.VOSR374_VS_VoS_RezeptTyp74_VS_VoS_RezeptTypactive2020-05
kbv.ita.vosR4KBV-VS-VoS-PrescriptionTypeKBV_VS_VoS_PrescriptionTypeactive2023-02
dk.kip.rkkp.fhir.ig.coreR4SygdomsomraaderAlleSygdomsområder - alleactive2023-05internal
dk.kip.rkkp.fhir.ig.coreR4SygdomsomraaderHaemaSygdomsområder - HÆMAactive2023-05internal
dk.kip.rkkp.fhir.ig.coreR4SygdomsomraaderDOFSygdomsområder - Ortopædkirurgiactive2023-05internal
de.basisprofil.r4R4UcumVitalsCommonDEUCUM Vitals Common DEactive2025-06hl7ucum
dk.kip.rkkp.fhir.ig.coreR4StraalebehandlingMaalStrålebehandlingens målactive2022-05internal
dk.kip.rkkp.fhir.ig.coreR4StraalebehandlingTAAllStrålebehandlinger mål - alleactive2022-05internal
dk.kip.rkkp.fhir.ig.coreR4AlleMaaleEnhederAlle Måleenhederactive2022-08internal
de.netzwerk-universitaetsmedizin.ebm-cpgR5vs-allergic-disposition-sctAllergic Disposition SCTdraft2022-09uvhl7sct
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20200901000000AllergieCategorieCodelijstactivenlhl7sct tho
nictiz.fhir.nl.stu3.zib2015R32.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20150401000000AllergieCategorieCodelijstretirednlfhir sct
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20171231000000AllergieCategorieCodelijstactivenlfhir sct
nictiz.fhir.nl.r4.zib2020R42.16.840.1.113883.2.4.3.11.60.40.2.8.2.3--20200901000000AllergieStatusCodelijstactivenlhl7tho
nictiz.fhir.nl.stu3.zib2015R32.16.840.1.113883.2.4.3.11.60.40.2.8.2.3--20150401000000AllergieStatusCodelijstretirednlfhir
nictiz.fhir.nl.stu3.zib2017R32.16.840.1.113883.2.4.3.11.60.40.2.8.2.3--20171231000000AllergieStatusCodelijstactivenlfhir
hl7.fhir.be.allergyR4be-allergyintolerancecodeBeAllergyIntoleranceCodeactive2025-07behl7internal
MyHIE.v4-testR4value-set-allergy-code-my-coreValueSetAllergyCode (MY Core)active2023-01
IdHIE.0vR4value-set-allergy-code-id-coreValueSetAllergyCode (ID Core)active2023-06
ans.fr.terminologiesR4jdv-hl7-allergy-intolerance-criticality-cisisAllergy Intolerance Criticalityactive2025-06frnationalfhir
MyHIE.v4-testR4value-set-allergy-negation-my-coreValueSetAllergyNegation (MY Core)active2023-03sct
IdHIE.0vR4value-set-allergy-negation-id-coreValueSetAllergyNegation (ID Core)active2023-06sct
nz.central.ihub.igR4nzcr-allergy-reaction-vsNZ Central Region - Allergy Reaction Value Setactive2025-04nznationaltho
MyHIE.v4-testR4value-set-allergy-active-ingredient-my-coreValueSetAllergyCode (MY Core)active2023-01
IdHIE.0vR4value-set-allergy-active-ingredient-id-coreValueSetAllergyCode (ID Core)active2023-06
nz.central.ihub.igR4nzcr-allergy-alert-code-vsNZ Central Region - Allergy Alert Code Value Setactive2025-04nznational
hl7.fhir.eu.hdrR4allergy-intolerance-eu-hdrAllergy Intolerance (with exceptions)draft12025-06euhl7internal fhir
hl7.fhir.eu.hdrR4allergy-intolerance-substances-eu-hdrAllergy Intolerancedraft12025-06euhl7sct
hl7.cda.uv.ipsR42.16.840.1.113883.11.22.2--20161206000000Allergy or Intolerance Typedraft2024-08uvhl7tho oid
healthdata.be.r4.cbbR4AllergyCategoryAllergyCategorydraftsct
ans.fr.terminologiesR4jdv-hl7-allergyintolerance-clinical-cisisAllergyIntolerance Clinical Status Codesactive2025-06frnationaltho
healthdata.be.r4.cbbR4AllergyStatusAllergyStatusdraftsct
egde.health.gatewayR4organisatorisk-betingelse-8624vsOrganisatorisk betegnelseactive2023-03oid
egde.health.gatewayR4documentype-9602-vsVolven 9602 Dokumenttyperactive2023-03oid
egde.health.gatewayR4specimen-type-vsSpecimen typesactive2023-03